Brief: Xvivo Q2 EBIT SEK 25 Million
BRIEF-Xvivo Q2 EBIT SEK 25 Million Jul 14 (Reuters) - Xvivo Q2 net income SEK 16.3 million.
- Q2 sales SEK 239 million vs. IBES estimate SEK 235.7 million
- Q2 EPS SEK 0.52
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength